- Home
- ACLX vs ELAN Comparison
ACLX vs ELAN Comparison
Compare ACLX & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACLX
- ELAN
- Stock Information
- Founded
- ACLX 2015
- ELAN 1954
- Country
- ACLX United States
- ELAN United States
- Employees
- ACLX N/A
- ELAN N/A
- Industry
- ACLX Biotechnology: Pharmaceutical Preparations
- ELAN Biotechnology: Pharmaceutical Preparations
- Sector
- ACLX Health Care
- ELAN Health Care
- Exchange
- ACLX Nasdaq
- ELAN Nasdaq
- Market Cap
- ACLX 5.3B
- ELAN 6.3B
- IPO Year
- ACLX 2022
- ELAN 2018
- Fundamental
- Price
- ACLX $87.83
- ELAN $13.97
- Analyst Decision
- ACLX Strong Buy
- ELAN Buy
- Analyst Count
- ACLX 14
- ELAN 6
- Target Price
- ACLX $103.67
- ELAN $17.00
- AVG Volume (30 Days)
- ACLX 667.5K
- ELAN 4.5M
- Earning Date
- ACLX 11-07-2024
- ELAN 11-07-2024
- Dividend Yield
- ACLX N/A
- ELAN N/A
- EPS Growth
- ACLX N/A
- ELAN N/A
- EPS
- ACLX N/A
- ELAN 0.41
- Revenue
- ACLX $155,818,000.00
- ELAN $4,454,000,000.00
- Revenue This Year
- ACLX $20.54
- ELAN $2.22
- Revenue Next Year
- ACLX N/A
- ELAN $2.77
- P/E Ratio
- ACLX N/A
- ELAN $33.88
- Revenue Growth
- ACLX 230.33
- ELAN 1.99
- 52 Week Low
- ACLX $46.42
- ELAN $11.40
- 52 Week High
- ACLX $107.37
- ELAN $18.80
- Technical
- Relative Strength Index (RSI)
- ACLX 46.33
- ELAN 56.31
- Support Level
- ACLX $99.95
- ELAN $12.35
- Resistance Level
- ACLX $107.37
- ELAN $14.71
- Average True Range (ATR)
- ACLX 5.90
- ELAN 0.49
- MACD
- ACLX -0.23
- ELAN 0.19
- Stochastic Oscillator
- ACLX 35.66
- ELAN 67.29
About ACLX Arcellx Inc.
Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.